Café

© 2026 Longbridge｜Terms of Service Privacy Policy

InMed Pharmaceuticals

INM

----

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

The 2026 Earnings Paradox: Record Revenues Meet Hidden Credit Cracks
Global Report·13 hours ago
EADSY+0.41%NSC+0.61%
The Biotech Survival Charade: Stop Buying the "AI Pivot" Hype
Global Report·14 hours ago
INM-7.57%ONCY-4.26%
The Great Unbundling of 2026: From AI Platforms to Physical Constraints
Global Report·1 day ago, 04:14 AM
MELI+0.15%HUBS+7.83%
The 2026 Biotech Divide: When Generative Biology Meets the FDA Wall
Global Report·2 days ago, 04:13 AM
INM-7.57%TXG-3.72%
Pre-market hot trades in US stocks: AsiaStrategy pre-market down 9.91%; InMed Pharmaceuticals pre-market down 9.04%
Price Alert·2 days ago, 04:12 AM
SORA-5.86%INM-7.57%
InMed Pharmaceuticals rises 8% in after-hours trading
US Stock Market Update·Jul 22 at 04:21 PM
INM-7.57%
InMed Pharmaceuticals surges 12% during regular trading on volume
US Stock Market Update·Jul 22 at 01:52 PM
INM-7.57%
InMed Pharmaceuticals surges 14% during regular trading
US Stock Market Update·Jul 22 at 11:11 AM
INM-7.57%
InMed Pharmaceuticals surges 33% during regular trading on heavy volume
US Stock Market Update·Jul 22 at 08:40 AM
INM-7.57%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga_article·Jul 22 at 07:05 AM
JUNS-20.92%INM-7.57%
Mentari Therapeutics merger with InMed set to close ahead of USD 200 million private placement
PUBT·Jul 22 at 06:05 AM
INM-7.57%
ADAR1 Capital acquires 1,000 InMed common shares worth $1,555
PUBT·Jul 17 at 06:30 PM
INM-7.57%
Vivo Opportunity reports USD 32,319 purchase of InMed common shares
PUBT·Jul 16 at 08:58 PM
INM-7.57%
InMed amends merger deal with Mentari, files S-4 registration statement
PUBT·Jul 10 at 03:03 PM
INM-7.57%